Applied DNA Sciences, Inc.
APDN
$2.98
-$0.28-8.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.30M | 3.47M | 3.41M | 3.11M | 3.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.30M | 3.47M | 3.41M | 3.11M | 3.07M |
| Cost of Revenue | 1.38M | 1.31M | 1.94M | 2.09M | 2.23M |
| Gross Profit | 934.10K | 1.17M | 1.47M | 1.01M | 848.40K |
| SG&A Expenses | 8.25M | 7.95M | 10.95M | 11.40M | 12.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.69M | 16.47M | 16.57M | 17.09M | 17.96M |
| Operating Income | -13.39M | -13.00M | -13.16M | -13.98M | -14.88M |
| Income Before Tax | -9.63M | -4.10M | -8.59M | -7.05M | -7.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.63 | -4.10 | -8.59 | -7.05 | -7.36 |
| Earnings from Discontinued Operations | -336.20K | -33.80K | -33.80K | -33.80K | -33.80K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 85.00K | 76.60K | 99.90K | 95.80K | 102.20K |
| Net Income | -13.19M | -7.36M | -8.53M | -6.99M | -7.29M |
| EBIT | -13.39M | -13.00M | -13.16M | -13.98M | -14.88M |
| EBITDA | -13.06M | -12.61M | -12.70M | -13.29M | -13.93M |
| EPS Basic | -867.64 | -887.84 | -657.54 | -240.01 | -- |
| Normalized Basic EPS | -192.45 | -188.53 | -188.53 | -149.54 | -- |
| EPS Diluted | -867.64 | -887.84 | -657.54 | -240.01 | -- |
| Normalized Diluted EPS | -192.45 | -188.53 | -188.53 | -149.54 | -- |
| Average Basic Shares Outstanding | 716.90K | 144.90K | 55.70K | 13.70K | -- |
| Average Diluted Shares Outstanding | 716.90K | 144.90K | 55.70K | 13.70K | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |